Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Robinson

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
The Journal of Infection|January 18, 2025
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort studyShuo Feng, Sagida Bibi, Parvinder K Aley, et al.
BMJ Open|November 25, 2025
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate <i>Streptococcus pneumoniae</i> serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15)Bruno Rocha de Macedo, Carla Solórzano, Angela Hyder-Wright, et al.
The Journal of Infectious Diseases|April 1, 2020
Low Sensitivity of BinaxNOW RSV in InfantsRoy P Zuurbier, Louis J Bont, Annefleur C Langedijk, et al.
The Journal of Infectious Diseases|August 15, 2020
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in EuropeJoanne G Wildenbeest, Roy P Zuurbier, Koos Korsten, et al.
The Journal of Infectious Diseases|January 25, 2024
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in InfantsMari Johnson, Irina Chelysheva, Deniz Öner, et al.
The Lancet. Respiratory Medicine|November 13, 2022
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyJoanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
The Journal of Biological Chemistry|July 23, 2013
Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic miceTatyana A Shelkovnikova, Owen M Peters, Alexey V Deykin, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
BMJ Open|January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocolMargarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
Cell|September 27, 2016
A Functional Role for Antibodies in TuberculosisLenette L Lu, Amy W Chung, Tracy R Rosebrock, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Infection|January 18, 2025
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort studyShuo Feng, Sagida Bibi, Parvinder K Aley, et al.
BMJ Open|November 25, 2025
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate <i>Streptococcus pneumoniae</i> serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15)Bruno Rocha de Macedo, Carla Solórzano, Angela Hyder-Wright, et al.
The Journal of Infectious Diseases|April 1, 2020
Low Sensitivity of BinaxNOW RSV in InfantsRoy P Zuurbier, Louis J Bont, Annefleur C Langedijk, et al.
The Journal of Infectious Diseases|August 15, 2020
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in EuropeJoanne G Wildenbeest, Roy P Zuurbier, Koos Korsten, et al.
The Journal of Infectious Diseases|January 25, 2024
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in InfantsMari Johnson, Irina Chelysheva, Deniz Öner, et al.
The Lancet. Respiratory Medicine|November 13, 2022
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyJoanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
The Journal of Biological Chemistry|July 23, 2013
Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic miceTatyana A Shelkovnikova, Owen M Peters, Alexey V Deykin, et al.
Medicine|January 9, 2015
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccineMainga Hamaluba, Rama Kandasamy, Susan Ndimah, et al.
BMJ Open|January 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against <i>Salmonella</i> Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocolMargarete Paganotti Vicentine, Naina McCann, Oisin Hennigan, et al.
Cell|September 27, 2016
A Functional Role for Antibodies in TuberculosisLenette L Lu, Amy W Chung, Tracy R Rosebrock, et al.
Pageof 11